Urinary biomarkers of mycobacterial load and treatment response in pulmonary tuberculosis

被引:8
|
作者
Xia, Qianjing [1 ]
Lee, Myung Hee [2 ]
Walsh, Kathleen F. [2 ,3 ]
McAulay, Kathrine [2 ,4 ]
Bean, James M. [5 ]
Fitzgerald, Daniel W. [2 ,3 ,6 ]
Dupnik, Kathryn M. [2 ,3 ]
Johnson, Warren D. [2 ,3 ,6 ]
Pape, Jean W. [2 ,6 ]
Rhee, Kyu Y. [2 ,3 ,4 ]
Isa, Flonza [3 ]
机构
[1] Weill Cornell Med Coll, New York, NY USA
[2] Weill Cornell Med, Ctr Global Hlth, New York, NY 10065 USA
[3] Weill Cornell Med, Dept Med, 1300 York Ave,Room A-421, New York, NY 10065 USA
[4] Weill Cornell Med, Dept Microbiol & Immunol, New York, NY 10065 USA
[5] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[6] Ctr GHESKIO, Port Au Prince, Haiti
关键词
N-1; N-12-DIACETYLSPERMINE; N-8-DIACETYLSPERMIDINE; DIAGNOSIS; SYSTEMS; HOST; TIME;
D O I
10.1172/jci.insight.136301
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BACKGROUND. Control of the tuberculosis (TB) pandemic remains hindered in part by a lack of simple and accurate measures of treatment efficacy, as current gold standard markers rely on sputum-based assays that are slow and challenging to implement. However, previous work identified urinary N-1, N-12-diacetylspermine (DiAcSpm), neopterin, hydroxykynurenine, N-acetylhexosamine, ureidopropionic acid, sialic acid, and mass-to-charge ratio (m/z) 241.0903 as potential biomarkers of active pulmonary TB (ATB). Here, we evaluated their ability to serve as biomarkers of TB treatment response and mycobacterial load. METHODS. We analyzed urine samples prospectively collected from 2 cohorts with ATB. A total of 34 study participants from African countries treated with first-line TB therapy rifampin, isoniazid, pyrazinamide, and ethambutol (HRZE) were followed for 1 year, and 35 participants from Haiti treated with either HRZE or an experimental drug were followed for 14 days. Blinded samples were analyzed by untargeted HPLC-coupled high-resolution TOF-mass spectrometry. RESULTS. Urinary levels of all 7 molecules significantly decreased by week 26 of successful treatment (P = 0.01 to P < 0.0001) and positively correlated with sputum mycobacterial load (P < 0.0001). Urinary DiAcSpm levels decreased significantly in participants treated with HRZE as early as 14 days (P < 0.0001) but remained unchanged in cases of ineffective therapy (P = 0.14). CONCLUSION. Urinary DiAcSpm, neopterin, hydroxykynurenine, N-acetylhexosamine, ureidopropionic acid, sialic acid, and m/z 241.0903 reductions correlated with successful anti-TB treatment and sputum mycobacterial load. Urinary DiAcSpm levels exhibited reductions capable of differentiating treatment success from failure as early as 2 weeks after the initiation of chemotherapy, advocating its further development as a potentially simple, noninvasive biomarker for assessing treatment response and bacterial load.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Radiological cavitation, sputum mycobacterial load and treatment response in pulmonary tuberculosis
    Perrin, F. M. R.
    Woodward, N.
    Phillips, P. P. J.
    McHugh, T. D.
    Nunn, A. J.
    Lipman, M. C. I.
    Gillespie, S. H.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2010, 14 (12) : 1596 - 1602
  • [2] Mass Spectrometric Identification of Urinary Biomarkers of Pulmonary Tuberculosis
    Isa, Flonza
    Collins, Sean
    Lee, Myung Hee
    Decome, Diessy
    Dorvil, Nancy
    Joseph, Patrice
    Smith, Lauren
    Salerno, Stephen
    Wells, Martin T.
    Fischer, Steven
    Bean, James M.
    Pape, Jean W.
    Johnson, Warren D.
    Fitzgerald, Daniel W.
    Rhee, Kyu Y.
    EBIOMEDICINE, 2018, 31 : 157 - 165
  • [3] Serum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis
    Jayakumar, A.
    Vittinghoff, E.
    Segal, M. R.
    MacKenzie, W. R.
    Johnson, J. L.
    Gitta, P.
    Saukkonen, J.
    Anderson, J.
    Weiner, M.
    Engle, M.
    Yoon, C.
    Kato-Maeda, M.
    Nahid, P.
    TUBERCULOSIS, 2015, 95 (04) : 415 - 420
  • [4] Serological biomarkers for monitoring response to treatment of pulmonary and extrapulmonary tuberculosis in children and adolescents
    dos Santos, Danielle C. M.
    Lovero, Kathryn L.
    Schmidt, Christiane M.
    Barros, Ana Claudia M. W.
    Quintanilha, Ana Paula
    Barbosa, Ana Paula
    Pone, Marcos V. S.
    Pone, Sheila M.
    Araujo, Julienne Martins
    Martins, Camila de Paula
    Cosme, Estela Magalhaes
    Dourado de Oliveira, Thais Raquelly
    Miceli, Ana Lucia
    Vieira, Maria Luiza
    Queiroz, Adriano
    Coca Velarde, Luis Guillermo
    Kritski, Afranio
    Pombo March, Maria de Fatima
    de Azevedo Sias, Selma Maria
    SantAAnna, Clemax C.
    Riley, Lee W.
    Araujo Cardoso, Claudete A.
    TUBERCULOSIS, 2020, 123
  • [5] Mycobacterium tuberculosis Zinc Metalloprotease-1 Elicits Tuberculosis-Specific Humoral Immune Response Independent of Mycobacterial Load in Pulmonary and Extra-Pulmonary Tuberculosis Patients
    Vemula, Mani H.
    Ganji, Rakesh
    Sivangala, Ramya
    Jakkala, Kiran
    Gaddam, Sumanlatha
    Penmetsa, Sitaramaraju
    Banerjee, Sharmistha
    FRONTIERS IN MICROBIOLOGY, 2016, 7
  • [6] Comparison of characteristics of patients and treatment outcome for pulmonary nontuberculous mycobacterial infection and pulmonary tuberculosis
    AlJarad, N
    Demertzis, P
    Jones, DJM
    Barnes, NC
    Rudd, RM
    Gaya, H
    Wedzicha, JA
    Hughes, DT
    Empey, DW
    THORAX, 1996, 51 (02) : 137 - 139
  • [7] Surgical Treatment of Nontuberculous Mycobacterial Pulmonary Disease and a Combination of Nontuberculous Mycobacterium Pulmonary Disease and Pulmonary Tuberculosis
    Giller, Dmitry Borisivich
    Shcherbakova, Galina Vladimirovna
    Gerasimov, Andrey Nikolaevich
    Smerdin, Sergey Viktorovich
    Martel, Ivan Ivanovich
    Kesaev, Oleg Schamilevich
    Koroev, Vadim Valerievich
    Severova, Lyudmila Petrovna
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 120 : 12 - 21
  • [8] Biomarkers That Correlate with Active Pulmonary Tuberculosis Treatment Response: a Systematic Review and Meta-analysis
    Zimmer, Alexandra J.
    Lainati, Federica
    Vasquez, Nathaly Aguilera
    Chedid, Carole
    McGrath, Sean
    Benedetti, Andrea
    MacLean, Emily
    Ruhwald, Morten
    Denkinger, Claudia M.
    Kohli, Mikashmi
    JOURNAL OF CLINICAL MICROBIOLOGY, 2022, 60 (02)
  • [9] Heterogeneity of antibody response to mycobacterial antigens in different clinical manifestations of pulmonary tuberculosis
    Demkow, U.
    Filewska, M.
    Michalowska-Mitczuki, D.
    Kus, J.
    Jagodzinski, J.
    Zielonka, T.
    Zwolska, Z.
    Wasik, M.
    Rowinska-Zakrzewska, E.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2007, 58 : 117 - 127
  • [10] Host biomarkers detected in saliva show promise as markers for the diagnosis of pulmonary tuberculosis disease and monitoring of the response to tuberculosis treatment
    Jacobs, Ruschca
    Tshehla, Enock
    Malherbe, Stephanus
    Kriel, Magdalena
    Loxton, Andre G.
    Stanley, Kim
    van der Spuy, Gian
    Walzl, Gerhard
    Chegou, Novel N.
    CYTOKINE, 2016, 81 : 50 - 56